Open-Label Phase II Study to Evaluate the Efficacy and Safety of IdeS in Anti-GBM Disease
Clinical trial NCT03157037 · COMPLETED
Trial details
- NCT number
- NCT03157037
- Sponsor
- Mårten Segelmark
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-16
- Primary completion
- 2020-07-24
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.